1. Home
  2. CSTM vs SUPN Comparison

CSTM vs SUPN Comparison

Compare CSTM & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTM
  • SUPN
  • Stock Information
  • Founded
  • CSTM 2010
  • SUPN 2005
  • Country
  • CSTM France
  • SUPN United States
  • Employees
  • CSTM N/A
  • SUPN N/A
  • Industry
  • CSTM Metal Fabrications
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSTM Industrials
  • SUPN Health Care
  • Exchange
  • CSTM Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • CSTM 1.9B
  • SUPN 2.0B
  • IPO Year
  • CSTM 2013
  • SUPN 2012
  • Fundamental
  • Price
  • CSTM $14.24
  • SUPN $42.64
  • Analyst Decision
  • CSTM Buy
  • SUPN Buy
  • Analyst Count
  • CSTM 3
  • SUPN 2
  • Target Price
  • CSTM $18.00
  • SUPN $41.00
  • AVG Volume (30 Days)
  • CSTM 1.5M
  • SUPN 1.0M
  • Earning Date
  • CSTM 07-29-2025
  • SUPN 08-05-2025
  • Dividend Yield
  • CSTM N/A
  • SUPN N/A
  • EPS Growth
  • CSTM N/A
  • SUPN 1411.53
  • EPS
  • CSTM 0.22
  • SUPN 1.14
  • Revenue
  • CSTM $7,605,000,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • CSTM $5.41
  • SUPN N/A
  • Revenue Next Year
  • CSTM $8.46
  • SUPN $15.74
  • P/E Ratio
  • CSTM $62.76
  • SUPN $37.26
  • Revenue Growth
  • CSTM 2.04
  • SUPN 5.55
  • 52 Week Low
  • CSTM $7.33
  • SUPN $29.16
  • 52 Week High
  • CSTM $17.27
  • SUPN $43.62
  • Technical
  • Relative Strength Index (RSI)
  • CSTM 56.48
  • SUPN 78.08
  • Support Level
  • CSTM $13.06
  • SUPN $40.26
  • Resistance Level
  • CSTM $14.01
  • SUPN $43.62
  • Average True Range (ATR)
  • CSTM 0.61
  • SUPN 1.76
  • MACD
  • CSTM -0.02
  • SUPN 0.70
  • Stochastic Oscillator
  • CSTM 50.00
  • SUPN 91.16

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: